events

Duopharma Biotech maintains robust revenue and profit growth momentum

Duopharma Biotech Berhad (Duopharma Biotech) reported a revenue of RM931.69 million for the year ended 31 December 2025, up 14.5% compared to revenue of RM813.70 million in financial year 2024. In line with increased revenue, profit for the year also saw robust growth, with profit before tax (PBT) for FY2025 growing 43.6% year-on-year to RM114.91 […]